| Drug Name |
Sulfisoxazole |
| Drug ID |
BADD_D02636 |
| Description |
A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms. |
| Indications and Usage |
For the treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections. |
| Marketing Status |
approved; vet_approved |
| ATC Code |
J01EB05; S01AB02 |
| DrugBank ID |
DB00263
|
| KEGG ID |
D00450
|
| MeSH ID |
D013444
|
| PubChem ID |
5344
|
| TTD Drug ID |
D09TBD
|
| NDC Product Code |
Not Available |
| UNII |
740T4C525W
|
| Synonyms |
Sulfisoxazole | Sulfasoxizole | Sulfadimethyloxazole | Sulfafurazole | Sulfafurazol FNA | Sulfisoxazole Diolamine | Diolamine, Sulfisoxazole | Sulfisoxazole, Ammonium Salt | Ammonium Salt Sulfisoxazole | Sulfisoxazole, Monolithium Salt | Monolithium Salt Sulfisoxazole | V-Sul | V Sul | Sulfisoxazole, Monosodium, Monomesylate Salt | Sulfisoxazole, Triammonium Salt | Triammonium Salt Sulfisoxazole | Gantrisin | Gantrisin Pediatric | Pediatric, Gantrisin | TL-azole | TL azole | Neoxazoi | Sulfisoxazole, Monosodium Salt | Monosodium Salt Sulfisoxazole |
